SIGA Technologies

SIGA Technologies

Drug Manufacturers - Specialty & Generic
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

$444M

Market Cap • 12/5/2025

1995

(30 years)

Founded

1997

(28 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country